Circle Pharma, based in South San Francisco, CA, is a biopharmaceutical company specializing in the development of macrocycle therapeutics to target undruggable proteins, with a primary focus on precision oncology. Utilizing a unique platform that integrates structure-based rational drug design and advanced synthetic chemistry, Circle Pharma aims to create innovative solutions for unmet clinical needs.
The company's groundbreaking approach has led to the presentation of compelling data in breast cancer treatment, showcasing the potential of their first-in-class Cyclin A/B inhibitor at the 2023 AACR-NCI-EORTC International Conference. Circle Pharma is actively seeking talented individuals to join their team as they continue to advance their pipeline of macrocycle therapeutics.
Generated from the website